Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck

被引：0
|
作者：
Keil, F. [1 ]
Selzer, E. [2 ]
Berghold, A. [3 ]
Reinisch, S. [4 ]
de Vries, A. [5 ]
Greil, R. [6 ]
Bachtiary, B. [7 ]
Tinchon, C. [8 ]
Anderhuber, W. [9 ]
Burian, M. [10 ]
Kasparek, A. K. [11 ]
Elsaesser, W. [12 ]
Kainz, H. [8 ]
Riedl, R. [3 ]
Kapp, K. [13 ]
Kopp, M. [14 ]
Kornek, G. [15 ,16 ]
机构：
[1] Hanuschkrankenhaus, Med Abt 3, Vienna, Austria
[2] Med Univ Vienna, Univ Clin Radiat Therapy & Radiat Biol, Vienna, Austria
[3] Inst Med Informat Stat & Documentat, Graz, Austria
[4] Med Univ Graz, Clin Dept Gen Head & Neck, Graz, Austria
[5] Landeskrankenhaus Feldkirch Radiat Therapy, Feldkirch, Austria
[6] Paracelsus Med Univ, Univ Clin Internal Med Salzburg 3, Salzburg, Austria
[7] Med Univ Vienna, Univ Clin Radiat Therapy & Radiat Biol, Vienna, Austria
[8] Landeskrankenhaus Leoben, Dept Internal Med Hemato & Oncol, Leoben, Austria
[9] Landeskrankenhaus Leoben, Dept Head & Neck, Leoben, Austria
[10] Hosp Barmherzige Schwestern Linz, Dept Head & Neck, Linz, Austria
[11] Univ Clin Internal Med Graz, Dept Clin Oncol, Graz, Austria
[12] Landeskrankenhaus Feldkirch, Dept Head & Neck, Feldkirch, Austria
[13] Univ Clin Radiat Therapy Radiooncol Graz, Graz, Austria
[14] Paracelsus Med Univ, Univ Clin Salzburg, Salzburg, Austria
[15] Med Univ Vienna, Gen Hosp Vienna, Dept Internal Med 1, Vienna, Austria
[16] Med Univ Vienna, Gen Hosp Vienna, Ctr Canc, Vienna, Austria
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P826
引用
下载
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [41] A phase II trial of nedaplatin, 5-fluorouracil and docetaxel for induction chemotherapy with local advanced squamous cell carcinoma of the head and neck
    Ueda, S.
    Nishikawa, D.
    Yane, K.
    Akashi, Y.
    Sakiyama, T.
    Terashima, M.
    Okabe, T.
    Yamaguchi, M.
    Matuura, T.
    Okajima, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck
    Hideaki Katori
    Mamoru Tsukuda
    Takahide Taguchi
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 789 - 794
  • [43] Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck
    Katori, Hideaki
    Tsukuda, Mamoru
    Taguchi, Takahide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) : 789 - 794
  • [44] Phase I trial of concurrent chemo radiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori, H
    Tsukuda, M
    Ishitoya, J
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Ono, M
    Hirose, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 503S - 503S
  • [45] Induction Chemotherapy with Docetaxel, Cisplatin and Fluorouracil Followed by Surgery and Concurrent Chemoradiotherapy Improves Outcome of Recurrent Advanced Head and Neck Squamous Cell Carcinoma
    Yang, Wen-Chi
    Chen, Chung-Ho
    Tang, Jen-Yang
    Wu, Chih-Fung
    Liu, Yi-Chang
    Sun, Youping
    Lin, Sheng-Fung
    ANTICANCER RESEARCH, 2014, 34 (07) : 3765 - 3773
  • [46] Compliance and efficacy of induction chemotherapy with cisplatin, docetaxel, and fluorouracil followed by radiotherapy plus cisplatin or cetuximab for locally advanced oropharyngeal tumours.
    Fuchsmann, Carine
    Fayette, Jerome
    Tartas, Sophie
    Favrel, Veronique
    Pommier, Pascal
    Zrounba, Philippe
    Ramade, Antoine
    Racadot, Severine
    Poupart, Marc
    Ceruse, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma.
    Biswas, Ghanashyam
    Ganta, Ranga Raman
    Kharthik, N.
    Kantharia, Rajesh
    Bondarde, Shailesh
    Raman, Ramaiyer Raghu
    Mahajan, Manoj
    Ahmad, Ateeq
    Sheikh, Saifuddin
    Ali, Shoukath M.
    Paithankar, Mahesh
    Patel, Lav
    Rajani, Anil
    Bunger, Deepak
    Chaturvedi, Alok
    Ahmad, Imran
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
    Kim, Ryul
    Hahn, Seokyung
    Shin, Junghoon
    Ock, Chan-Young
    Kim, Miso
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 907 - 916
  • [49] Economic evaluation of the TAX 324 trial comparing docetaxel plus cisplatin and 5-fluorouracil (TPF) versus standard treatment with cisplatin and 5-fluorouracil (PF) as induction chemotherapy followed by concurrent chemoradiation therapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Parthan, A.
    Posner, M. R.
    Brammer, C.
    Beltran, P.
    Jansen, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Rate of complete pathological responses (pCR) to docetaxel/cisplatin/5-fluorouracil (TPF) induction chemotherapy in patients with newly diagnosed, locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Haddad, RI
    Tishler, R
    Wirth, L
    Norris, C
    Goguen, L
    Sullivan, C
    O'Donnell, L
    Li, Y
    Posner, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 502S - 502S
12345